Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Inclusion Criteria: * Subjects having understood and signed an informed consent form * Male or female subjects who are 18 to 35 years (both included) of age presenting acne vulgaris of the face. * A minimum of 10 inflammatory lesions (papules and pustules) on the entire face, and a minimum of 20 non-inflammatory lesions (open comedones and closed comedones) on the entire face. * Disease severity grade as mild or moderate according to the investigator's global assessment (grade 2 or grade 3) Exclusion Criteria: * Females who are pregnant, of child-bearing potential and who wish to become pregnant during the study, or who are breast feeding. * Subjects with any acne cysts or more than one nodule per hemiface. * Subjects with acne conglobata, acne fulminans, secondary acne (e.g. chloracne, drug-induced acne), or any acne requiring systemic treatment. * Subjects with a dark pigmentation of the skin or skin type that may, in any way, confound interpretation of the study results (skin type V or VI on Fitzpatrick scale. * Subjects with other facial skin disorders that may interfere with study assessments. * Subjects who will use medicated cosmetics and/or soaps (including soaps containing antibacterial agents such as benzoyl peroxide, keratolytic agents such as salicylic acid, skin fresheners/astringents or aftershave products) on the face for the duration of the study. * Subjects with a history of actinic keratosis on the face or skin cancer. * Use of hormonal oral contraceptive…